Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2010
09/22/2010CN101301289B Uses of berberine and analog thereof in pump for reversing multidrug resistance
09/22/2010CN101263830B Multi-effect pesticidal preparations and uses thereof
09/22/2010CN101234094B Dipyridamole orally disintegrating tablet
09/22/2010CN101229331B Medicine for treating anorexia, limosis and preparing method thereof
09/22/2010CN101181626B Transfer factor capsule and preparation method thereof
09/22/2010CN101153052B Uridine peptide antibiotic, pharmaceutically acceptable salt, producing method and uses thereof
09/22/2010CN101129493B Antineoplastic anti-AIDS pharmaceutical composition and method of preparing the same
09/21/2010USRE41745 Vector; genetic vaccines for humans or horses; side effect reduction; increasing the protectiveness of a vaccinia-based vaccine
09/21/2010US7799901 capable of modulating or mediating the FAS receptor ligand or TNF effect on cells carrying FAS receptor or p55 receptor by binding or interacting with MORT-1 (mediators of receptor toxicity) protein
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799793 N-alkylated rifampin
09/21/2010US7799762 Functionally substituted amino acids, having fatty acid chains bound through amidification of the amine functional groups of dipeptide like compounds, one end bears a functional side chain and other side neutral or charged acid
09/21/2010US7799353 Pharmaceutical mixture for hepatitis treatment and its preparation method
09/21/2010CA2444123C Novel arylsulfonamides as antiviral agents
09/21/2010CA2441629C Antibiotic pharmaceutical composition with lysergol as bio-enhancer and method of treatment
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2433280C Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
09/21/2010CA2408746C Antisense phosporodiamidate morpholino oligonucleotide inhibition of cytochrome p450 to modulate drug pharmacokinetics
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/21/2010CA2369292C Method of modulating the activity of functional immune molecules
09/21/2010CA2330241C Attenuated pestiviruses
09/21/2010CA2327353C Structural proteins of fish pancreatic disease virus and uses thereof
09/21/2010CA2307142C N-terminally chemically modified protein compositions and methods
09/17/2010CA2658714A1 Hcv-derived polypeptides and uses thereof
09/16/2010WO2010105191A2 Antimicrobial compositions and methods of use therefore
09/16/2010WO2010104341A2 Compositions for diagnosis of fungal infections
09/16/2010WO2010104052A1 Humanized pcrv antibody having anti-pseudomonal activity
09/16/2010WO2010103306A1 Benzimidazole derivatives and their use as antivaral agents
09/16/2010WO2010103119A1 Compositions and methods for elimination of gram-negative bacteria
09/16/2010WO2010103095A1 Tetrahydronaphthalen-2-ol derivatives
09/16/2010WO2010102363A1 Auxotrophic, recombinant bcg strain pasteur and use thereof for combating human infections caused by parasites
09/16/2010WO2010086617A3 Phosphoantigens for the treatment of burkholderia infections
09/16/2010WO2010082726A3 Process for purifying vancomycin wet body
09/16/2010WO2010068920A3 Diaminoquinazoline inhibitors of dihydrofolate reductase
09/16/2010WO2010067202A3 Mixing lyophilised meningococcal vaccines with non-hib vaccines
09/16/2010WO2010067201A3 MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH D-T-Pa VACCINES
09/16/2010WO2010065110A3 Antimicrobials
09/16/2010WO2010057141A3 Alphavirus inhibitors and uses thereof
09/16/2010WO2010053583A3 Small molecule cd4 mimetics and uses thereof
09/16/2010WO2010021697A3 Antibodies to ccr2
09/16/2010US20100235936 Zinc-finger nuclease and rna interference mediated inactivation of viral genomes
09/16/2010US20100234460 Compositions Comprising A C2-C14 Carboxylic Acid And A Surfactant For Treating Hoof Diseases
09/16/2010US20100234448 In vivo production of small interfering rnas that mediate gene silencing
09/16/2010US20100234434 Flavivirus inhibition by sultams and related compounds
09/16/2010US20100234410 Hydrate for medical purposes
09/16/2010US20100234405 Pyrimidine nucleoside derivatives and salts thereof
09/16/2010US20100234404 P-38 Kinase Inhibitors
09/16/2010US20100234390 Novel compound and their use
09/16/2010US20100234375 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
09/16/2010US20100234370 Pharmaceutical compounds
09/16/2010US20100234369 5-cyanothienopyridines for the treatment of tumours
09/16/2010US20100234367 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010US20100234348 Compositions and methods for potentiating antibiotic activity
09/16/2010US20100234339 Silver(i) compounds and their use in pharmaceutical compositions for the treatment,prophylaxis and prevention of infections
09/16/2010US20100234335 Neurosteroid compounds
09/16/2010US20100234324 Quinazolinamide derivatives
09/16/2010US20100234316 Nucleoside Aryl Phosphoramidates for the Treatment of RNA-Dependent RNA Viral Infection
09/16/2010US20100234313 Stabilized micronised particles
09/16/2010US20100234311 Methicillin-Resistant Staphylococcus Aureus Active Metabolites
09/16/2010US20100234306 Use of a peptide as a therapeutic agent
09/16/2010US20100234281 Antibacterial antisense oligonucleotide and method
09/16/2010US20100234280 Antisense antibacterial method and compound
09/16/2010US20100233810 In vivo production of small interfering rnas that mediate gene silencing
09/16/2010US20100233785 Novel methods and interferon deficient substrates for the propagation of viruses
09/16/2010US20100233299 Topical phytotherapeutic compound for the treatment of herpes based on uncaria tomentosa and extraction process for obtaining a vegetal extract from uncaria tomentosa
09/16/2010US20100233294 Use of tellurium compounds for inhibition of interleukin-converting enzyme
09/16/2010US20100233292 Germicidal composition
09/16/2010US20100233285 Honey based compositions of a consistency that can be delivered to the respiratory system
09/16/2010US20100233284 Method and composition for treatment of yeast infection through a radial appliance or a wet-cell battery appliance and solution jar set
09/16/2010US20100233279 Compositions And Methods Comprising Analogues Of Radicicol A
09/16/2010US20100233273 Polymer compositions with bioactive agent, medical articles, and methods
09/16/2010US20100233270 Delivery of Oligonucleotide-Functionalized Nanoparticles
09/16/2010US20100233264 TEMPERATURE AND pH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFTY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF
09/16/2010US20100233250 Vaccine
09/16/2010US20100233213 Recombinant BCG Strains with Enhanced Ability to Escape the Endosome
09/16/2010US20100233210 Subgenomic replicons of the flavivirus dengue
09/16/2010US20100233209 Chikungunya virus infectious clones and uses therefor
09/16/2010US20100233208 Methods of Treating and Preventing Neurological Symptoms Caused by Avian Reovirus and Novel Associated Characteristics
09/16/2010US20100233207 C-glycolipids with enhanced th-1 profile
09/16/2010US20100233206 Marek's Disease Virus Vaccine Compositions and Methods of Using Thereof
09/16/2010US20100233205 Adjuvanted antigenic meningococcal compositions
09/16/2010US20100233203 Optimized early-late promoter combined with repeated vaccination favors cytotoxic t cell response against recombinant antigen in mva vaccines
09/16/2010US20100233202 Novel viral vector
09/16/2010US20100233201 Vaccine composition
09/16/2010US20100233182 Antibodies against Clostridium difficile toxins and uses thereof
09/16/2010US20100233181 Antibodies against clostridium difficile toxins and uses thereof
09/16/2010US20100233166 Novel ido inhibitors and methods of use
09/16/2010US20100233157 Human antibodies against human fas and their use
09/16/2010US20100233143 Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells
09/16/2010US20100233129 Prevention and treatment of secondary infections following viral infection
09/16/2010US20100233122 Novel benzimidazole derivatives
09/16/2010US20100233120 Hepatitis C Virus Inhibitors
09/16/2010US20100233117 Adjuvant combination formulations
09/16/2010US20100233104 Amino-Acid Functional Siloxanes, Methods Of Preparation and Applications
09/16/2010US20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof
09/16/2010DE102009047562A1 Agent comprises peptide compounds, useful for capturing or inhibiting avian influenza virus and in biosensor for detecting or capturing avian influenza virus
09/16/2010CA2754900A1 Humanized pcrv antibody having anti-pseudomonal activity
09/16/2010CA2754604A1 Compositions and methods for elimination of gram-negative bacteria
09/16/2010CA2754603A1 Non-integrating retroviral vector vaccines
09/16/2010CA2754109A1 Infectious disease cellular immunotherapy
1 ... 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 ... 1798